Introduction
Increasing knowledge about the mechanisms involved in the development of seizures, as well as improved understanding of the cellular effects of antiepileptic drugs (AED), have resulted in links between demonstrated molecular actions of these drugs and the types of seizures against which they are effective. A number of AEDs have been synthesized, with the goal of adapting synaptic function in order to regulate seizure frequency or occurrence. "First generation" AEDs include carbamazepine (CBZ), phenytoin (PHY), phenobarbital and valporate, whereas felbamate, gabapentin, lamotrigine (LTG), topiramate, levitrcetam, oxcarbazepine (ox-CBZ) and zonisamide are classified as "second generation" AEDs. Aromatic AEDs include CBZ, PHY and phenobarbital. 1 CBZ and PHY are structurally related to one another, while LTG is not. PHY is para-hydroxylated by cytochrome p450s primarily to two enantiomers, and further metabolized to a catechol that spontaneously oxidizes to semiquinone and quinine species. [2] [3] [4] Major CBZ metabolism pathways include oxidation, hydration to 2-and 3-hydroxy-CBZ, which can be further oxidized to a catechol or an iminoquinone. 5, 6 LTG is largely metabolized in the liver by glucuronic acid conjugation, producing a 2-N-glucuronide conjugate, which can be hydrolyzed to beta-glucuronidase. 7 Interactions between AEDs are important in examining drug function and metabolism. CBZ and PHY decrease the half-life of LTG in the body, while valporate increases it. 8 Hypersensitivity reactions (HSR) are a common feature of anticonvulsants, being noted in 30%
and 70% of patients with drug-induced liver injury (DILI) caused by CBZ and PHY, respectively. 9, 10 To establish whether a drug is the cause of an immune-mediated reaction, alternative causes, latency of a reaction after drug intake, improvement after drug cessation, previous patient cases, and rechallenge have to be examined. 9 CBZ, PHY and LTG have been associated with HSRs. LTG was reported to produce Stevens- Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and DILI. [11] [12] [13] Most HSR cases occur during the first eight weeks of treatment. [14] [15] [16] [17] HSRs refer to dose-independent, idiosyncratic, severe adverse drug reactions (ADR). 18, 19 Clinically, a triad of fever, rash and organ manifestation defines a "true" HSR. 9, 18, 20, 21 Skin manifestations include exanthematous rash, blistering eruptions such as erythema multiforme, SJS and TEN. 16, [22] [23] [24] [25] SJS and TEN are severe cutaneous adverse reactions (SCAR). [26] [27] [28] [29] [30] [31] [32] [33] [34] Epidermal detachment below 10% is defined as SJS, whereas it is considered TEN above 30% [35, 36] . Epidermal detachment between 10% and 30% defines transitional SJS/TEN. 37, 38 The incidence of TEN is estimated between 1-2 cases/million people/year, with a mortality rate of 30%, whereas there are 2-7 cases/million people/year of SJS, with a mortality rate of 1-3%. 39, 41 AEDs are among the leading causes of SCAR, [42] [43] [44] drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) 42, 45, 46 and DILI. 47 Interestingly, while AEDs were the second leading cause of cutaneous ADRs, CBZ (10.3%) and PHY (9.6%) were the AEDs most often implicated, with CBZ the primary cause of SJS/TEN (24.0%) in Malaysia. 48 Genetic markers such as the human leukocyte antigen (HLA) are useful in predicting an individual's predisposition AED-HSR. Ever since it was first linked with CBZ-SJS in Han Chinese, 49 HLA allele B*1502 (HLA-B*1502) has become the strongest HLA correlation among human diseases (98% negative predictive value, 92% sensitivity and 4.2%-19% false positivity). 50 This association holds true for certain ethnic groups only, in particular Han Chinese, Thai, Malay and to a lesser degree, Indians. 50, 51 HSR cases accompanied by hepatocytotoxicity are fewer than HSR cases with dermatologic presentations. DILI may lead to liver failure and transplant. 10, 25 Regardless of ethnicity, HSR predisposition can be predicted by the in vitro lymphocyte toxicity assay (LTA). 52, 53 The mitochondrial enzyme succinate dehydrogenase-based LTA was validated versus clinical manifestations. 53 Neuman et al. 53 also validated the new colorimetric methodology versus the previous LTA based on trypan blue uptake measured by microscopic counting of cells. 52 Reactive metabolites of drugs are generated using murine hepatic microsomes as a source of cytochrome p450s. 16, 53, 54 The neurologist (PH) established the causality to a specific drug and the hepatologist (LC) was consulted for cases presenting liver involvement. The clinical biochemist and pharmacology specialist (MN) was responsible for the study design, the laboratory diagnosis and the technical procedures, as well as writing the paper with the toxicology specialist (RN). Ethical approval for the study was obtained from the Scientific and Ethics Review Committees of the North York General Hospital, Toronto, Canada. All patients signed the informed consent form before participating in the study. The LTA was performed 2-3 years after the HSR in patients presenting at the clinic with a non-active adverse event. A single blood sample was drawn from each patient, which was used to extract the lymphocytes for the LTA and to obtain the sera for the cytokine analysis. Anonymous clinical description was matched to each sample.
CHEMICALS
Chemicals were purchased from Sigma-Aldrich (St. Louis, Missouri, USA). Microsomes were obtained from mice induced to a certain cytochrome p450 as previously described. 53 The microsomal solution was diluted in HEPES buffer. Gibco® (InVitrogen; Carlsbad, California, USA)
is the manufacture of Dulbecco's modified eagle medium (α-MEM). Generic drugs (CBZ, LTG)
were manufactured by Apotex Inc. (North York, Ontario, Canada, http://www.apotex.com/ca/en/search.asp).
PREPARATION OF THE LTA
Samples belonging to both sensitive and tolerant patients were incubated in the presence or absence of the microsomal fraction as previously described. 53 The parental drug was added at its therapeutic concentration. 53 The HLA polymorphism was determined using the method described by Kazeem et al. We also took into consideration all the non-drug risk factors such as chronic diseases (e.g. cancer, trauma) that required chronic therapeutic interventions in addition to AEDs. Also, we noted existing radiotherapy, recent viral disease or chronic viral infection.
Results
All patients with clinical manifestations to AEDs presented positive LTA to the incriminating drug.
Controls tolerant to the drug presented negative LTA to the respective drugs. Figure 1 In the present work, we define the cytokine levels in the sera of controls tolerant to AED and HSR patients ( Table 1 ). There is a clear partition between the levels of cytokines in controls, patients presenting only with rush, and patients presenting with the triad of rash, fever and organ involvement. Patients presenting with SJS/TEN and DILI show elevated levels of Fas and caspase 8, pointing to the apoptotic processes involved in the immunopathogenesis of severe adverse events such as DILI and SJS/TEN. There is a statistical difference between the levels of cytokines in control individuals and patients presenting adverse reactions and between patients presenting only with rash and patients presenting with DILI or SJS/TEN (Table 1) .
Discussion
It is crucial to have a complete understanding of the biochemical processes that occur during HSR since it would allow for a better comprehension of any predisposing factors, potential crossreactivity, and the required duration of treatment. Ultimately, this analysis would aid clinicians in their assessment and decisions regarding potential therapies or the possible switch of the present therapy to a more effective one. The LTA is an in vitro assay that allows assessment of potential HSRs to a drug metabolite. This test is based on mitochondria dysfunction and a lack of drug detoxification capabilities in people sensitive to certain drugs. Several surveillance strategies have evolved that limit mitochondrial damage and ensure cellular integrity.
Intraorganellar proteases conduct protein quality control and exert regulatory functions, allowing mitochondria to protect against apoptosis. Cell death caused by the metabolite can be detected as mitochondrial damage upon exposure to reactive drug metabolites. 53 Mitochondrial damage may only signify a fraction of the complications involved in HSR, but it is a critical one nonetheless. Defects in any of the five complexes in the respiratory chain would greatly add to mitochondrial toxicity. 57 The LTA is a marker of one such disorder, as it highlights genetic deficiencies in succinate dehydrogenase, a specific enzyme part of complex II in the mitochondrial respiratory chain. Since succinate dehydrogenase is specific to mitochondrial activity, its dysfunction would indicate cell death when the cell is subjected to stress. 53 We have already performed similar studies in individuals who presented HSR to AEDs. 16, 53 The present study confirms that the LTA can predict an HSR to AEDs in an ethnically-specific population of
Han Chinese individuals living in Canada, an environment different from that which their "mainland" ancestors were exposed to. There is no overlap in the patients studied in the prior work and the patients studied in the present work. The present work validates the usefulness of this diagnostic and predictive assay to be utilized in possible HSR reaction to AEDs, mainly in individuals of Asian descent living in Canada, while the main population studied in our previous studies was Caucasian. In the current study, AED samples were segregated into tolerant and hypersensitive groups.
Cross-reactivity to anticonvulsants was observed clinically for a number of decades between CBZ, PHY and valproic acid. 33, [59] [60] [61] [62] [63] [64] In the present work, we observed cross-reactivity between LTG and CBZ. The phenomenon may be explained by the ability of T-cells to recognize the major histocompatibility complex (MHC) of a drug-MHC complex. We demonstrated that the LTA is able to indicate a possible clinical AEDs cross-reactivity.
Early diagnosis of an HSR is important in improving the quality of life in patients. The high frequency of rashes and a lack of efficacy are the main reasons for medication substitution in anti-epilepsy therapy. To avoid possible HSRs, testing is strongly advised. The LTA allows neurologists a routine analysis to predict and prevent an adverse reaction. The test may eventually help elucidate the mechanism of cytotoxicity caused by reactive metabolites, and the patterns of inheritance of defects in detoxification pathways.
Our group analyzed the composition of circulating cytokines and their cellular expression in lymphocytes, using markers of cell activation such as the Fas/Fas ligand system. 16 Our results confirmed that the apoptotic pathway is significantly activated in SJS/TEN. 55 Fujita et al.
described the role of inflammatory cytokines IL-1 and IL-5, and chemokines CCL5, CCL17 and CXCL10 in cutaneous immune inflammation. 65 In our previous work, 55 we demonstrated the immunochemical presence of apoptosis and necrosis markers in the skin biopsy of a patient with TEN, as well as the clear distribution of pro-inflammatory cytokines in the sera of patients with ibuprofen-induced SJS/TEN.
The present work confirms that an HSR is a clinical reaction with genetic (HLA) and immune (cytokines) markers significantly different in susceptible versus tolerant individuals. Also, levels of cytokines differ between patients presenting only rash and patients presenting the triad of rash, fever and organ involvement (Table 1) . Patients presenting with SJS/TEN or DILI show elevated levels of Fas and caspase 8, pointing to the apoptotic processes involved in the immunopathogenesis of severe adverse events such as DILI and SJS/TEN (Table 1) . Cytokines released by the inflammatory process have the potential to alter oxidative drug metabolism, thereby increasing the production and toxicity of reactive drug metabolites therefore leading to toxic events. Pro-inflammatory cytokines expressed as a result of T-cell activation may represent a danger signal for HSR, as demonstrated by our findings. However, excluding neutrophils, these cells are also antigen-presenting cells, and are thus capable of biotransformation, conjugation and immune cell stimulation. In the present work, there is a positive correlation between LTG-DILI/SJS cases and the serum level of chemo-attractant substances such as chemokines (IL-8, RANTES and monocyte chemo-attractant protein). Similar results have been shown in our previous work. 57 Pro-inflammatory cytokines such as IL-1α and TNF-α are molecules that stimulate the synthesis of acute-phase proteins. 66 IL-18 is pro-inflammatory at a very early step in the immune response. IL-6 stimulates most acute-phase proteins, while IL-10 is a prototype anti-inflammatory cytokine that regulates B-cell function. 16 Moreover, Fas was shown to be dysregulated in SJS/TEN. 55, 67 T-cell memory is responsible for the recognition of "stress" signals represented by the exposure of lymphocytes to the insulting drug. We demonstrated a clear link between genetic factors such as HLA and immune responses to a specific injury. The more severe the injury, the higher the level of inflammatory responses and apoptosis were.
The present work also takes into consideration the possibility that patients that are prone to HSR may develop cross-reactivity due to a structural similarity between CBZ and PHY, but also to an The high incidence of HLA-B*1502 among Asian individuals (10-15%) correlates with a high incidence of SJS/TEN in this population (17 to 25 in every 10000 individuals in Taiwan and Thailand), compared to its low incidence among Caucasians (1% to 2%), which correlates with a low incidence in this population (1 to 6 in every 10000 individuals). 49, 50, 82 No association was found between LTG-SJS/TEN and HLA-B*1502 in Chinese, 68 or European patients. 58 In our study, we observed that negative HLA-B*1502 does not predict negative LTG-HSR. We conclude that HLA-B*1502-negative status is not protective against LTG-HSR. For HLA-B*1502-negative patients wishing to take LTG, an LTA is highly advised in order to ensure tolerance towards this anticonvulsant. The main limitation of our study is the relatively small number of Han Chinese patients presenting AED-HSR who participated in the study. confirmed that the LTA is a valuable method for predicting and confirming HSR to a specific drug.
Conclusion
We have proposed that the LTA could be used as a screen tool for those considering taking or changing AEDs, as means to avoid an HSR. Our study emphasizes the necessity to wisely monitor the patients clinically and by laboratory investigations when prescribing AEDs, in order to avoiding AED-HSRs. Personalized medicine and assessing individual risk to adverse drug reaction is important for physicians and patients, since alternatives for the drugs involved may be needed for future safe treatment.
Financial Disclosure/Acknowledgements Table 1 Cytokines Patients were grouped based on the clinically presentation of their symptoms as controls tolerating the drug (white), HSR patients presenting only rash and fever (grey) or patients presenting a triad of rash, fever and SJS/TEN or DILI that characterizes "true" HSR (black). The LTA value is given as mean percentage of toxicity and standard deviation (SD) in lymphocyte toxicity for each drug.
